Bone marrow stromal cell interaction reduces Syndecan-1 expression and induces kinomic changes in myeloma cells
- 20 March 2010
- journal article
- Published by Elsevier BV in Experimental Cell Research
- Vol. 316 (11), 1816-1828
- https://doi.org/10.1016/j.yexcr.2010.03.013
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- APRIL and TACI interact with syndecan‐1 on the surface of multiple myeloma cells to form an essential survival loopEuropean Journal of Haematology, 2009
- Autologous Hematopoietic Stem-Cell Transplantation for Multiple MyelomaNew England Journal of Medicine, 2009
- Emerging therapies for multiple myelomaEmerging Drugs, 2009
- Tumorigenic potential and disease manifestations of malignant B-cell variants differing in their fibronectin adhesivenessExperimental Hematology, 2008
- Maintenance of Quiescent Hematopoietic Stem Cells in the Osteoblastic NicheAnnals of the New York Academy of Sciences, 2007
- Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myelomaOncogene, 2006
- The paradox of response and survival in cancer therapeuticsBlood, 2006
- The Phenotypic Plasticity of Myeloma Plasma Cells as Expressed by Dedifferentiation into an Immature, Resilient, and Apoptosis-Resistant PhenotypeClinical Cancer Research, 2005
- Characterization of clonogenic multiple myeloma cellsBlood, 2004
- Bone marrow stromal-derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanismsLeukemia, 2003